Not Yet RecruitingEarly Phase 1

Comparison of Permethrin-Based Treatment Strategies Against Scabies in Infants and Young Children

Pakistan68 participantsStarted 2026-01-15

Plain-language summary

To compare the efficacy of different permethrin-based therapies for scabies infestations in infants and young children.

Who can participate

Age range1 Month – 4 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1 month to 4 years age. * Both gender * Scabies as defined in operational definition Exclusion Criteria: * • Drug sensitivity test results for hypersensitivity to permethrin * Having renal or hepatic impairment. * Individuals with additional long-term skin and systemic disorders (such as diabetes, hypertension, asthma, epilepsy, acne, psoriasis)

What they're measuring

Treatment of scabies

Timeframe: 15 days

Trial details

NCT IDNCT07247630

SponsorCollege of Physicians and Surgeons Pakistan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-15

Contact for this trial

Shanza zafar, MBBs

+923425316096 shanza444@gmail.com

View on ClinicalTrials.gov More Scabies trials